Authors: | Nabors, L. B.; Portnow, J.; Ammirati, M.; Brem, H.; Brown, P.; Butowski, N.; Chamberlain, M. C.; Deangelis, L. M.; Fenstermaker, R. A.; Friedman, A.; Gilbert, M. R.; Hattangadi-Gluth, J.; Hesser, D.; Holdhoff, M.; Junck, L.; Lawson, R.; Loeffler, J. S.; Moots, P. L.; Mrugala, M. M.; Newton, H. B.; Raizer, J. J.; Recht, L.; Shonka, N.; Shrieve, D. C.; Sills, A. K. Jr; Swinnen, L. J.; Tran, D.; Tran, N.; Vrionis, F. D.; Wen, P. Y.; McMillian, N. R.; Ho, M. |
Article Title: | Central nervous system cancers, version 2.2014 |
Abstract: | The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations for the clinical management of patients with cancers of the central nervous system. These NCCN Guidelines Insights highlight recent updates regarding the management of metastatic brain tumors using radiation therapy. Use of stereotactic radiosurgery (SRS) is no longer limited to patients with 3 or fewer lesions, because data suggest that total disease burden, rather than number of lesions, is predictive of survival benefits associated with the technique. SRS is increasingly becoming an integral part of management of patients with controlled, low-volume brain metastases. |
Keywords: | cancer survival; cancer radiotherapy; brain tumor; practice guideline; central nervous system tumor; patient care; brain metastasis; continuing education; stereotactic radiosurgery; predictive value; human; article |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 12 |
Issue: | 11 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2014-11-01 |
Start Page: | 1517 |
End Page: | 1523 |
Language: | English |
PROVIDER: | scopus |
PUBMED: | 25361798 |
PMCID: | PMC4337873 |
DOI/URL: | |
Notes: | Export Date: 1 December 2014 -- Source: Scopus |